CWIAX
Price
$82.59
Change
+$0.54 (+0.66%)
Updated
Jun 2 closing price
Net Assets
151.89B
HEONX
Price
$20.96
Change
+$0.25 (+1.21%)
Updated
Jun 2 closing price
Net Assets
132.25M
Interact to see
Advertisement

CWIAX vs HEONX

Header iconCWIAX vs HEONX Comparison
Open Charts CWIAX vs HEONXBanner chart's image
CWIAX vs HEONX Comparison Chart in %
View a ticker or compare two or three
VS
CWIAX vs. HEONX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and HEONX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 152B vs. HEONX (132M). CWIAX pays higher dividends than HEONX: CWIAX (1.33) vs HEONX (0.00). CWIAX was incepted earlier than HEONX: CWIAX (24 years) vs HEONX (10 years). HEONX (1.98) is less costly to investors than CWIAX (0.75). HEONX is a more actively managed with annual turnover of: 61.00 vs. CWIAX (44.00). CWIAX has a lower initial minimum investment than HEONX: CWIAX (250) vs HEONX (2000). HEONX annual gain was more profitable for investors over the last year : 24.91 vs. CWIAX (22.44). CWIAX return over 5 years is better than : 38.19 vs. HEONX (22.98).
CWIAXHEONXCWIAX / HEONX
Total Expense Ratio0.751.9439%
Annual Report Gross Expense Ratio0.751.9838%
Fund Existence24 years10 years-
Gain YTD15.65219.02382%
Front Load4%N/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets152B132M115,152%
Annual Yield % from dividends1.330.00-
Returns for 1 year22.4424.9190%
Returns for 3 years54.6540.60135%
Returns for 5 years38.1922.98166%
Returns for 10 years122.6387.80140%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHAX12.600.20
+1.61%
NYLI Cushing® MLP Premier Class A
JCPRX25.76N/A
N/A
JPMorgan US Large Cap Core Plus R5
OIEIX26.19N/A
N/A
JPMorgan Equity Income A
RYBOX65.18N/A
N/A
Rydex Biotechnology A
PSKCX23.33N/A
N/A
Virtus KAR Mid-Cap Growth C